| Smiles |
S(=O)(=O)(OC9(C(O)C(OC3(OC(C(OC1(OC(C(O)C(C1O)OC2(OC(C(O)C(C2O)OC)CO))CO))C(C3O)O)C))C(OC8(C(C6(C(C5(=CC(O)C47(C(=O)OC(C4(O)CCC7(C5CC6)(C))(CCC(O)C(=C)C)C)))(C)CC8))(C)C))OC9))O
|
| CAS number |
97243-47-5
|
| Polar Surface Area |
424,11
|
| calculated LogS |
-3,332
|
| Molweight |
1199,32
|
| calculated LogP |
-3,1179
|
| H-Acceptors |
27
|
| H-Donors |
13
|
| Ro5 violations |
3
|
| Druglikeness |
-16,751
|
| DrugScore |
0,2301815
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,1987
|
| Rat Acute Toxicity |
2,7742
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,1803
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,7122
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB+
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
High HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
97243-47-5
|
